These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3392652)

  • 21. Effect of chronic caffeine intake on choice reaction time, mood, and visual vigilance.
    Judelson DA; Armstrong LE; Sökmen B; Roti MW; Casa DJ; Kellogg MD
    Physiol Behav; 2005 Aug; 85(5):629-34. PubMed ID: 16043199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous caffeine in stimulant drug abusers: subjective reports and physiological effects.
    Rush CR; Sullivan JT; Griffiths RR
    J Pharmacol Exp Ther; 1995 Apr; 273(1):351-8. PubMed ID: 7714788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeine reinforcement demonstrated in a majority of moderate caffeine users.
    Evans SM; Critchfield TS; Griffiths RR
    Behav Pharmacol; 1994 Jun; 5(3):231-238. PubMed ID: 11224272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gestational exposure to methylmercury retards choice in transition in aging rats.
    Newland MC; Reile PA; Langston JL
    Neurotoxicol Teratol; 2004; 26(2):179-94. PubMed ID: 15019952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues.
    Evans SM; Griffiths RR
    Behav Pharmacol; 1991 Nov; 2(4 And 5):345-356. PubMed ID: 11224078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How habitual caffeine consumption and dose influence flavour preference conditioning with caffeine.
    Tinley EM; Durlach PJ; Yeomans MR
    Physiol Behav; 2004 Sep; 82(2-3):317-24. PubMed ID: 15276794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement.
    Griffiths RR; Chausmer AL
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Nov; 20(5):223-31. PubMed ID: 11326548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reinforcing and subjective effects of several anorectics in normal human volunteers.
    Chait LD; Uhlenhuth EH; Johanson CE
    J Pharmacol Exp Ther; 1987 Sep; 242(3):777-83. PubMed ID: 3656112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the reinforcing and subjective effects of different doses of nitrous oxide using a free-choice procedure.
    Walker DJ; Zacny JP
    Drug Alcohol Depend; 2002 Mar; 66(1):93-103. PubMed ID: 11850141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeine improves anticipatory processes in task switching.
    Tieges Z; Snel J; Kok A; Wijnen JG; Lorist MM; Richard Ridderinkhof K
    Biol Psychol; 2006 Aug; 73(2):101-13. PubMed ID: 16549227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of caffeine in chewing gum on mood and attention.
    Smith A
    Hum Psychopharmacol; 2009 Apr; 24(3):239-47. PubMed ID: 19330801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual differences in responses to ethanol and d-amphetamine: a within-subject study.
    Holdstock L; de Wit H
    Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of diazepam and oxazepam: preference, liking and extent of abuse.
    Griffiths RR; McLeod DR; Bigelow GE; Liebson IA; Roache JD; Nowowieski P
    J Pharmacol Exp Ther; 1984 May; 229(2):501-8. PubMed ID: 6716272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ibuprofen plus caffeine in the treatment of tension-type headache.
    Diamond S; Balm TK; Freitag FG
    Clin Pharmacol Ther; 2000 Sep; 68(3):312-9. PubMed ID: 11014413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of caffeine on alcohol reinforcement: beverage choice, self-administration, and subjective ratings.
    Sweeney MM; Meredith SE; Evatt DP; Griffiths RR
    Psychopharmacology (Berl); 2017 Mar; 234(5):877-888. PubMed ID: 28108773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.
    Griffiths RR; Bigelow GE; Liebson I; Kaliszak JE
    J Pharmacol Exp Ther; 1980 Dec; 215(3):649-61. PubMed ID: 7441524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nighttime versus daytime hypnotic self-administration.
    Roehrs T; Bonahoom A; Pedrosi B; Zorick F; Roth T
    Psychopharmacology (Berl); 2002 May; 161(2):137-42. PubMed ID: 11981593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.